The pandemic has driven unprecedented demand for remote patient monitoring tools. But for all their tech-savvy convenience, they have yet to overcome major barriers that prevent their adoption among larger swaths of the U.S. population.
Once dominated by bulky devices designed for patients with a narrow set of severe chronic disorders, the RPM space has boomed in recent years, with tech giants and medical startups racing to develop everything from virtual diagnostics to health trackers. But the field still faces several big hurdles to reach its true market potential, from limited internet and device access among rural and low-income populations to public wariness around new tools and looming concerns about privacy.
About the Author Reprints
